BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 30599080)

  • 21. Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer.
    Wu Y; Lyu H; Liu H; Shi X; Song Y; Liu B
    Sci Rep; 2016 Aug; 6():31093. PubMed ID: 27489122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
    Zhang G; An X; Zhao H; Zhang Q; Zhao H
    Biomed Pharmacother; 2018 Feb; 98():594-599. PubMed ID: 29289833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lncRNA FEZF1-AS1 Promotes the Progression of Colorectal Cancer Through Regulating OTX1 and Targeting miR-30a-5p.
    Li J; Zhao LM; Zhang C; Li M; Gao B; Hu XH; Cao J; Wang GY
    Oncol Res; 2020 Feb; 28(1):51-63. PubMed ID: 31270006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
    Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
    Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of MBNL1-AS1 contributes to tumorigenesis of NSCLC via sponging miR-135a-5p.
    Cao G; Tan B; Wei S; Shen W; Wang X; Chu Y; Rong T; Gao C
    Biomed Pharmacother; 2020 May; 125():109856. PubMed ID: 32092823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcription factor ETV1-induced lncRNA MAFG-AS1 promotes migration, invasion, and epithelial-mesenchymal transition of pancreatic cancer cells by recruiting IGF2BP2 to stabilize ETV1 expression.
    Weng H; Feng W; Li F; Huang D; Lin L; Wang Z
    Growth Factors; 2023 Aug; 41(3):152-164. PubMed ID: 37428861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y; Ni R; Wang J; Liu Y
    Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
    Liu T; Yang C; Wang W; Liu C
    Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway.
    Shi J; Yang C; An J; Hao D; Liu C; Liu J; Sun J; Jiang J
    J Exp Clin Cancer Res; 2021 Apr; 40(1):148. PubMed ID: 33931086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA DNAH17-AS1 promotes tumorigenesis and metastasis of non-small cell lung cancer via regulating miR-877-5p/CCNA2 pathway.
    Du LJ; Mao LJ; Jing RJ
    Biochem Biophys Res Commun; 2020 Dec; 533(3):565-572. PubMed ID: 32981678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FAM83A-AS1 promotes lung adenocarcinoma cell migration and invasion by targeting miR-150-5p and modifying MMP14.
    Xiao G; Wang P; Zheng X; Liu D; Sun X
    Cell Cycle; 2019 Nov; 18(21):2972-2985. PubMed ID: 31522616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinogenic roles of MAFG-AS1 in human cancers.
    Ahmadi M; Morshedzadeh F; Ghaderian SMH; Mousavi P; Habibipour L; Peymani M; Abbaszadegan MR; Ghafouri-Fard S
    Clin Transl Oncol; 2024 Jan; 26(1):52-68. PubMed ID: 37351806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. lncRNA
    Yang J; Lin X; Jiang W; Wu J; Lin L
    DNA Cell Biol; 2019 Sep; 38(9):1013-1021. PubMed ID: 31386568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
    Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
    Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
    Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway.
    Peng W; He D; Shan B; Wang J; Shi W; Zhao W; Peng Z; Luo Q; Duan M; Li B; Cheng Y; Dong Y; Tang F; Zhang C; Duan C
    Cell Death Dis; 2019 Jul; 10(7):533. PubMed ID: 31296840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA DLGAP1-AS1 modulates the development of non-small-cell lung cancer via the microRNA-193a-5p/DTL axis.
    Pan X; Chen S; Ye L; Xu S; Wang L; Sun Y
    Lab Invest; 2022 Nov; 102(11):1182-1191. PubMed ID: 36183046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.